4//SEC Filing
Burkly Linda 4
Accession 0001650664-25-000025
CIK 0001650664other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:41 PM ET
Size
449.0 KB
Accession
0001650664-25-000025
Insider Transaction Report
Form 4
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2025-03-04$1.71/sh−2,891$4,946→ 70,245 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001985604
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:41 PM ET
- Size
- 449.0 KB